Erratum

This article refers to:

Current and future pharmacological treatment strategies with regard to aortic disease in Marfan syndrome

In the article “Current and future pharmacological treatment strategies with regard to aortic disease in Marfan syndrome” by Hartog et al. (Expert Opin Pharmocother 2012:13(5):647-62), some errors have been identified.

There were some errors in the formatting of Table 2. The correct version of the table is shown below.

Table

Institution (Study)	Start date	Follow up (months)	Design	Age range (years)	Target no. cases	Clinical endpoints	Tool
Boston Children's Hospital, Pediatric Heart Network Lacro et al.	January 2007	36	DB, RCT: losartan vs atenolol	0.5 – 25	604	Change in AoR diameter	Ultrasound
National Taiwan University Hospital (LOSARTAN) Wu et al.	February 2007	Unknown	OF, RCT: losartan and atenolol vs propanolol	≥ 1	44	Change in AoR diameter	Ultrasound
Brigham and Women's Hospital Creager et al.	October 2007	6	DB, RCT: losartan vs atenolol	≥ 50	50	Aortic biophysical properties	Ultrasound + arterial tonometry
Heart and Stroke Foundation of Canada Sandor et al.	January 2008	12	DB, RCT: losartan vs atenolol	12 – 25	30	Aortic biophysical properties	Ultrasound
Academic Medical Center (COMPARE) Mulder et al.	February 2008	36	OB, RCT: losartan vs no losartan	≥ 18	330	Change in AoR diameter	Ultrasound + MRI
Policlinico St. Matteo HospitalGambarin et al.	July 2008	48	OB, RCT: losartan vs nebivolol or combined	1 – 55	291	Change in AoR diameter	Ultrasound
Hospital Bichat Paris (Marfan Sartan) Detaint et al.	September 2008	36	DB, RCT: losartan vs placebo	≥ 10	300	Change in AoR diameter	Ultrasound
Ghent Hospital (Ghent Marfan Trial) Moberg et al.	June 2009	36	DB, RCT: losartan vs placebo	≥ 10	174	AoR diameter at any level, CA diameter	Ultrasound + MRI
Royal Brompton Harefield Foundation (The AIMS Trial) Mullen et al.	September 2010	45	DB, RCT: irbesartan vs placebo	6 – 40	490	Change in AoR diameter	Ultrasound
Hospital Universitario Vall d’Hebron Forteza et al.	October 2010	36	DB, RCT: losartan vs atenolol	5 – 60	150	Change in AoR, CA diameter	Ultrasound + MRI

AoP: Aortic root; CA: Carotid artery; DB: Double-blind; echo: Echocardiography; MRI: Magnetic resonance imaging; OB: Open label, blinded endpoints; OF: Open factorial; RCT: Randomized controlled trial.

Informa Healthcare apologise for the error and for any inconvenience caused.

In addition, there were two errors in the affiliation list for this article. Maarten Groenink should be linked to affiliation 4 (Department of Radiology) rather than 3 (Department of Clinical Epidemiology and Biostatistics). Secondly, the term ‘Professor of Cardiology’ should not have been mentioned as part of affiliation 1; this title only applies to Barbara JM Mulder.